Cronos (CRON) EBT Margin Growth (1y) (2019 - 2026)
Cronos (CRON) EBT Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cronos | 1.20 Bn | 407.87 Mn | 28.45 Mn | 13,874.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13,874.00 |
| Mar 31, 2026 | -3,530.00 |
| Dec 31, 2025 | 149,153.00 |
| Sep 30, 2025 | 1,787.00 |
| Jun 30, 2025 | -33,301.00 |
| Mar 31, 2025 | 8,745.00 |
| Dec 31, 2024 | -132,904.00 |
| Sep 30, 2024 | 4,890.00 |
| Jun 30, 2024 | -562.00 |
| Mar 31, 2024 | 26,380.00 |
| Dec 31, 2023 | -29,508.00 |
| Sep 30, 2023 | 14,037.00 |
| Jun 30, 2023 | 4,317.00 |
| Mar 31, 2023 | -14,684.00 |
| Dec 31, 2022 | -197,377.00 |
| Sep 30, 2022 | -200,277.00 |
| Jun 30, 2022 | 107,866.00 |
| Mar 31, 2022 | 115,246.00 |
| Dec 31, 2021 | 298,117.00 |
| Sep 30, 2021 | 123,530.00 |